Related references
Note: Only part of the references are listed.Comparing Angiotensin II Receptor Blockers on Benefits Beyond Blood Pressure
Helmy M. Siragy
ADVANCES IN THERAPY (2010)
Inhibition of Angiotensin-Converting Enzyme 2 Exacerbates Cardiac Hypertrophy and Fibrosis in Ren-2 Hypertensive Rats
Aaron J. Trask et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Direct Renin Inhibitors as Antihypertensive Agents
Zafar H. Israili et al.
AMERICAN JOURNAL OF THERAPEUTICS (2010)
Role of Angiotensin-Converting Enzyme Inhibitors in Vascular Modulation: Beyond the Hypertensive Effects
Srikanth Katragadda et al.
AMERICAN JOURNAL OF THERAPEUTICS (2010)
Impact of acute myocardial ischemia reperfusion on the tissue and blood-borne renin-angiotensin system
Shizu Oyamada et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Not just angiotensinases: new roles for the angiotensin-converting enzymes
Daniel W. Lambert et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Limiting angiotensin II signaling with a cell-penetrating peptide mimicking the second intracellular loop of the angiotensin II type-I receptor
Jun Yu et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
JiuChang Zhong et al.
CIRCULATION (2010)
Circulating Rather Than Cardiac Angiotensin-(1-7) Stimulates Cardioprotection After Myocardial Infarction
Yong Wang et al.
CIRCULATION-HEART FAILURE (2010)
Immunization against angiotensins for the treatment of hypertension
Patrik Maurer et al.
CLINICAL IMMUNOLOGY (2010)
Effects of Angiotensin Metabolites in the Coronary Vascular Bed of the Spontaneously Hypertensive Rat Loss of Angiotensin II Type 2 Receptor-Mediated Vasodilation
Els Moltzer et al.
HYPERTENSION (2010)
Cardiac-Specific Activation of Angiotensin II Type 1 Receptor-Associated Protein Completely Suppresses Cardiac Hypertrophy in Chronic Angiotensin II-Infused Mice
Hiromichi Wakui et al.
HYPERTENSION (2010)
Therapeutic Implications of the Vasoprotective Axis of the Renin-Angiotensin System in Cardiovascular Diseases
Anderson J. Ferreira et al.
HYPERTENSION (2010)
New Physiological Concepts of the Renin-Angiotensin System From the Investigation of Precursors and Products of Angiotensin I Metabolism
Carlos M. Ferrario
HYPERTENSION (2010)
Angiotensin I-Converting Enzyme Inhibitors Are Allosteric Enhancers of Kinin B1 and B2 Receptor Function
Ervin G. Erdoes et al.
HYPERTENSION (2010)
Nuclear-delimited Angiotensin Receptor-mediated Signaling Regulates Cardiomyocyte Gene Expression
Artavazd Tadevosyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents
Chih-Chang Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro
Maria Paz Ocaranza et al.
JOURNAL OF HYPERTENSION (2010)
Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats
Joep H. M. van Esch et al.
JOURNAL OF HYPERTENSION (2010)
Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB
Jose L. Miguel-Carrasco et al.
JOURNAL OF INFLAMMATION-LONDON (2010)
New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Chymase as an Important Target to Prevent Organ Damage
Shinji Takai et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
Iike Sipahi et al.
LANCET ONCOLOGY (2010)
Cardiac mast cell proteases do not contribute to the regulation of the rat coronary vascular responsiveness to arterial delivered angiotensin I and II
Luiz B. Bispo-da-Silva et al.
VASCULAR PHARMACOLOGY (2010)
Interaction between vasopressin and angiotensin II in vivo and in vitro: effect on aquaporins and urine concentration
Weidong Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
The Use of Ultralow Doses of Antibodies to C-Terminal Fragment of Angiotensin II AT1 Receptor (Kardos) in the Therapy of Arterial Hypertension
V. I. Petrov et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics
Hamish C. G. Prosser et al.
CARDIOVASCULAR RESEARCH (2009)
Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy
Scott D. Solomon et al.
CIRCULATION (2009)
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Mariell Jessup et al.
CIRCULATION (2009)
Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction
Zamaneh Kassiri et al.
CIRCULATION-HEART FAILURE (2009)
The intracellular renin-angiotensin system in the heart
Rajesh Kumar et al.
CURRENT HYPERTENSION REPORTS (2009)
Angiotensin II Type 2 Receptor Antagonizes Angiotensin II Type 1 Receptor-Mediated Cardiomyocyte Autophagy
Enzo R. Porrello et al.
HYPERTENSION (2009)
Cardiac Renin Levels Are Not Influenced by the Amount of Resident Mast Cells
Manne Krop et al.
HYPERTENSION (2009)
Onset of Experimental Severe Cardiac Fibrosis Is Mediated by Overexpression of Angiotensin-Converting Enzyme 2
Rachel Masson et al.
HYPERTENSION (2009)
Cytosolic renin is targeted to mitochondria and inducesapoptosis in H9c2 rat cardiomyoblasts
Heike Wanka et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Achieving blood pressure goals: should angiotensin II receptor blockers become first-line treatment in hypertension?
Michael Weber
JOURNAL OF HYPERTENSION (2009)
Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats
Fedor Simko et al.
JOURNAL OF HYPERTENSION (2009)
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
Marvin A. Konstam et al.
LANCET (2009)
Angiotensin II Type 2 Receptor Stimulation A Novel Option of Therapeutic Interference With the Renin-Angiotensin System in Myocardial Infarction?
Elena Kaschina et al.
CIRCULATION (2008)
Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
Chantal Mercure et al.
CIRCULATION RESEARCH (2008)
Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure
John J. V. McMurray et al.
CIRCULATION-HEART FAILURE (2008)
Intracellular Angiotensin II Production in Diabetic Rats Is Correlated With Cardiomyocyte Apoptosis, Oxidative Stress, and Cardiac Fibrosis
Vivek P. Singh et al.
DIABETES (2008)
Angiotensin-(1-7): Pharmacological properties and pharmacotherapeutic perspectives
Dilek Iusuf et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages
Susan B. Gurley et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide
Sandra Feldt et al.
HYPERTENSION (2008)
Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology
Shant Der Sarkissian et al.
HYPERTENSION (2008)
Angiotensin II-induced vasodilation via type 2 receptor:: Role of bradykinin and nitric oxide
Katsutoshi Yayama et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Angiotensin II:: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks
K.-D. Schlueter et al.
PHARMACOLOGY & THERAPEUTICS (2008)
The role of angiotensin AT1 receptor-associated protein in renin-angiotensin system regulation and function
Kouichi Tamura et al.
CURRENT HYPERTENSION REPORTS (2007)
Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and anti- inflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertension
Hongmei Peng et al.
HYPERTENSION (2007)
Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models
Mizuo Miyazaki et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion
CJ Mackins et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Angiotensin II induces apoptosis in vivo in skeletal, as well as cardiac, muscle of the rat
JG Burniston et al.
EXPERIMENTAL PHYSIOLOGY (2005)
The AT2 receptor - A matter of love and hate
UM Steckelings et al.
PEPTIDES (2005)
Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components
M Kurdi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells
K Kohlstedt et al.
CIRCULATION RESEARCH (2004)
Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases
LJ Dell'Italia et al.
CURRENT OPINION IN CARDIOLOGY (2002)
Share Paper
